Cargando…

Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity

Scaffolding the calcium/calmodulin-dependent phosphatase 2B (PP2B, calcineurin) focuses and insulates termination of local second messenger responses. Conformational flexibility in regions of intrinsic disorder within A-kinase anchoring protein 79 (AKAP79) delineates PP2B access to phosphoproteins....

Descripción completa

Detalles Bibliográficos
Autores principales: Nygren, Patrick J, Mehta, Sohum, Schweppe, Devin K, Langeberg, Lorene K, Whiting, Jennifer L, Weisbrod, Chad R, Bruce, James E, Zhang, Jin, Veesler, David, Scott, John D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653234/
https://www.ncbi.nlm.nih.gov/pubmed/28967377
http://dx.doi.org/10.7554/eLife.30872
_version_ 1783273204141260800
author Nygren, Patrick J
Mehta, Sohum
Schweppe, Devin K
Langeberg, Lorene K
Whiting, Jennifer L
Weisbrod, Chad R
Bruce, James E
Zhang, Jin
Veesler, David
Scott, John D
author_facet Nygren, Patrick J
Mehta, Sohum
Schweppe, Devin K
Langeberg, Lorene K
Whiting, Jennifer L
Weisbrod, Chad R
Bruce, James E
Zhang, Jin
Veesler, David
Scott, John D
author_sort Nygren, Patrick J
collection PubMed
description Scaffolding the calcium/calmodulin-dependent phosphatase 2B (PP2B, calcineurin) focuses and insulates termination of local second messenger responses. Conformational flexibility in regions of intrinsic disorder within A-kinase anchoring protein 79 (AKAP79) delineates PP2B access to phosphoproteins. Structural analysis by negative-stain electron microscopy (EM) reveals an ensemble of dormant AKAP79-PP2B configurations varying in particle length from 160 to 240 Å. A short-linear interaction motif between residues 337–343 of AKAP79 is the sole PP2B-anchoring determinant sustaining these diverse topologies. Activation with Ca2(+)/calmodulin engages additional interactive surfaces and condenses these conformational variants into a uniform population with mean length 178 ± 17 Å. This includes a Leu-Lys-Ile-Pro sequence (residues 125–128 of AKAP79) that occupies a binding pocket on PP2B utilized by the immunosuppressive drug cyclosporin. Live-cell imaging with fluorescent activity-sensors infers that this region fine-tunes calcium responsiveness and drug sensitivity of the anchored phosphatase.
format Online
Article
Text
id pubmed-5653234
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-56532342017-10-25 Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity Nygren, Patrick J Mehta, Sohum Schweppe, Devin K Langeberg, Lorene K Whiting, Jennifer L Weisbrod, Chad R Bruce, James E Zhang, Jin Veesler, David Scott, John D eLife Biochemistry and Chemical Biology Scaffolding the calcium/calmodulin-dependent phosphatase 2B (PP2B, calcineurin) focuses and insulates termination of local second messenger responses. Conformational flexibility in regions of intrinsic disorder within A-kinase anchoring protein 79 (AKAP79) delineates PP2B access to phosphoproteins. Structural analysis by negative-stain electron microscopy (EM) reveals an ensemble of dormant AKAP79-PP2B configurations varying in particle length from 160 to 240 Å. A short-linear interaction motif between residues 337–343 of AKAP79 is the sole PP2B-anchoring determinant sustaining these diverse topologies. Activation with Ca2(+)/calmodulin engages additional interactive surfaces and condenses these conformational variants into a uniform population with mean length 178 ± 17 Å. This includes a Leu-Lys-Ile-Pro sequence (residues 125–128 of AKAP79) that occupies a binding pocket on PP2B utilized by the immunosuppressive drug cyclosporin. Live-cell imaging with fluorescent activity-sensors infers that this region fine-tunes calcium responsiveness and drug sensitivity of the anchored phosphatase. eLife Sciences Publications, Ltd 2017-10-02 /pmc/articles/PMC5653234/ /pubmed/28967377 http://dx.doi.org/10.7554/eLife.30872 Text en © 2017, Nygren et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Biochemistry and Chemical Biology
Nygren, Patrick J
Mehta, Sohum
Schweppe, Devin K
Langeberg, Lorene K
Whiting, Jennifer L
Weisbrod, Chad R
Bruce, James E
Zhang, Jin
Veesler, David
Scott, John D
Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
title Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
title_full Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
title_fullStr Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
title_full_unstemmed Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
title_short Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
title_sort intrinsic disorder within akap79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
topic Biochemistry and Chemical Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653234/
https://www.ncbi.nlm.nih.gov/pubmed/28967377
http://dx.doi.org/10.7554/eLife.30872
work_keys_str_mv AT nygrenpatrickj intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT mehtasohum intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT schweppedevink intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT langeberglorenek intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT whitingjenniferl intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT weisbrodchadr intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT brucejamese intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT zhangjin intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT veeslerdavid intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity
AT scottjohnd intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity